CLOs on the Move

Genentech

www.gene.com

 
Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for over 35 years. At Genentech, we use human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious or life-threatening medical conditions. Today, we are among the world`s leading biotech companies, with multiple products on the market and a promising development pipeline.
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.gene.com
  • 1 DNA Way Mailstop 258A
    South San Francisco, CA USA 94080
  • Phone: 650.225.1000

Executives

Name Title Contact Details
Jinhee Chang
Intellectual Property Counsel Profile
Fred Medick
General Counsel Profile
Aviva Gilbert
Assistant General Counsel, Senior Profile
Yan Qi
Director and Assistant General Counsel, Platforms Profile
Sarah Tully
Director and Assistant General Counsel Profile

Similar Companies

BreakBio

BreakBio Corp is a biotechnology company focused on breakthrough cancer treatment and prevention. They use their proprietary AI platform to find multiple proteins on each patients cancer cells and custom manufacture drugs for each patient. Their goal ...

Biotix Holdings

Biotix Holdings is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

Novara Tesija Michela and Priehs

Novara Tesija Michela and Priehs is a Southfield, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Quintessence Biosciences Inc

Quintessence Biosciences Inc is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

RuiYi

RuiYi is focused on the discovery and development of novel biologic therapeutics that have the potential to be disruptive globally. In addition to RYI-018 and RYI-008, RuiYi has a growing pipeline of monoclonal antibodies from its internal discovery efforts utilizing a series of the Company's technologies, including the iCAPS (intramembranous Conformation Antigen Presenting System). Targets include a select subset of G protein coupled receptors (GPCR), where specificity in binding is critical but has proven difficult to achieve with small molecule modulators. RuiYi's executive management team has offices in La Jolla, California, and RuiYi's discovery efforts and research facility are located in in the Zhangjiang Hi-Tech Park in Pudong, Shanghai, China.